News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
329,628 Results
Type
Article (19732)
Company Profile (138)
Press Release (309758)
Section
Business (105245)
Career Advice (875)
Deals (18510)
Drug Delivery (93)
Drug Development (50683)
Employer Resources (79)
FDA (7653)
Job Trends (7725)
News (185622)
Policy (17305)
Tag
Academia (726)
Alliances (27778)
Alzheimer's disease (593)
Antibody-drug conjugate (ADC) (67)
Approvals (7637)
Artificial intelligence (97)
Bankruptcy (171)
Best Places to Work (5537)
Biosimilars (72)
Breast cancer (88)
Cancer (772)
Cardiovascular disease (77)
Career advice (708)
Cell therapy (113)
Clinical research (42127)
Collaboration (319)
Compensation (106)
COVID-19 (1080)
C-suite (88)
Data (803)
Diabetes (113)
Diagnostics (1732)
Drug pricing (99)
Earnings (38367)
Employer resources (73)
Events (47948)
Executive appointments (308)
FDA (8032)
Funding (226)
Gene therapy (105)
GLP-1 (527)
Government (1806)
Healthcare (5879)
Infectious disease (1137)
Inflammatory bowel disease (74)
Interviews (115)
IPO (7329)
Job creations (2431)
Job search strategy (646)
Layoffs (259)
Legal (4086)
Lung cancer (122)
Manufacturing (153)
Medical device (1952)
Medtech (1955)
Mergers & acquisitions (11309)
Metabolic disorders (386)
Neuroscience (810)
NextGen: Class of 2025 (2352)
Non-profit (904)
Northern California (829)
Obesity (248)
Opinion (179)
Patents (90)
People (33117)
Pharmaceutical (78)
Phase I (13167)
Phase II (17822)
Phase III (14331)
Pipeline (379)
Policy (78)
Postmarket research (1617)
Preclinical (4595)
Radiopharmaceuticals (157)
Rare diseases (175)
Real estate (3166)
Regulatory (12274)
Research institute (816)
Resumes & cover letters (138)
Southern California (763)
Startups (2006)
United States (7565)
Vaccines (223)
Weight loss (207)
Date
Today (74)
Last 7 days (208)
Last 30 days (971)
Last 365 days (17472)
2025 (873)
2024 (17678)
2023 (19638)
2022 (25865)
2021 (26639)
2020 (24871)
2019 (20058)
2018 (15587)
2017 (17253)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (406)
Asia (24636)
Australia (3168)
California (1888)
Canada (888)
China (223)
Colorado (77)
Connecticut (77)
Europe (50803)
Florida (289)
Illinois (190)
Indiana (140)
Japan (77)
Maryland (278)
Massachusetts (1596)
Minnesota (106)
New Jersey (723)
New York (540)
North Carolina (406)
Northern California (829)
Ohio (68)
Pennsylvania (445)
South America (605)
Southern California (763)
Texas (252)
Washington State (170)
329,628 Results for "fennec pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Press Releases
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference - December 12, 2024
December 13, 2024
·
1 min read
Press Releases
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
November 14, 2024
·
1 min read
Press Releases
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
December 20, 2024
·
10 min read
Press Releases
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management
December 19, 2024
·
8 min read
Bio NC
Fennec Announces Results of Annual Meeting - June 25, 2024
Fennec Pharmaceuticals Inc. announced that the nominees listed in the management proxy circular dated April 29, 2024 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in New York, New York on June 25, 2024.
June 25, 2024
·
1 min read
Business
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, reported its financial results for the first quarter ended March 31, 2024, and provided a business update.
May 14, 2024
·
14 min read
Press Releases
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
November 7, 2024
·
15 min read
Press Releases
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
October 31, 2024
·
1 min read
Business
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024.
May 7, 2024
·
1 min read
1 of 32,963
Next
